YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition
Launched by HIRABAI COWASJI JEHANGIR MEDICAL RESEARCH INSTITUTE · Oct 27, 2022
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aims and Objectives
Aim:
This cohort aims to study the adolescent growth trajectory of girls and boys aged 8 to 10 years from rural Maharashtra. The impact of these indicators on their future offspring size will be studied by following the adolescent cohort and assessing their intergenerational nutritional status till their first offspring is 5 years old.
Objectives:
1. To study trajectories of growth (height/ weight/ body mass index/ growth velocity) among young adolescents aged 8 to 10 years in rural areas of Maharashtra.
2. To longitudinally study the acquisition of bone mass, muscle...
Gender
ALL
Eligibility criteria
- • Inclusion
- • Age between 8 and 10 years during the period of enrollment
- • Children with both biological parents (mother and father) present during the period of enrollment
- • Apparently healthy children
- • Exclusion
- • Any chronic untreated/ progressive condition that would adversely affect growth, bone and/or muscle health of the participant
- • Migrant families and temporary residents as defined by Census of India (Office of the Registrar General \& Census Commissioner, India Ministry of Home Affairs, 2022)
- • Refusal to give informed consent and/or parental assent
About Hirabai Cowasji Jehangir Medical Research Institute
The Hirabai Cowasji Jehangir Medical Research Institute (HCJMRI) is a premier clinical research organization dedicated to advancing medical science through innovative research and development. Established with a commitment to enhancing healthcare outcomes, HCJMRI focuses on conducting high-quality clinical trials across various therapeutic areas. The institute collaborates with healthcare professionals, regulatory bodies, and industry partners to ensure rigorous adherence to ethical standards and regulatory compliance. With a team of experienced researchers and state-of-the-art facilities, HCJMRI aims to contribute significantly to evidence-based medicine and the development of novel therapeutic interventions, thereby improving patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pune, Maharashtra, India
Patients applied
Trial Officials
Anuradha V Khadilkar, MD
Principal Investigator
HCJMRI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials